Analyst Recommendations
33.86 1.59(4.93%)10/04/2024
Tarsus Pharmaceuticals Inc (TARS)
Tarsus Pharmaceuticals Inc (TARS)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 3 |
Outperform | 3 |
Overweight | 2 |
Neutral | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades